The case for & against
Bull & Bear analysis
Bearish
DocGo Inc. (NASDAQ: DCGO) is an innovative healthcare company specializing in mobile health solutions, including telemedicine and medical transportation services. The company is rapidly expanding its footprint in the telehealth sector, focusing on acute and critical care telemedicine, which positions it favorably within the ongoing transition to integrated care models in the healthcare industry. Through strategic acquisitions and operational efficiencies, DocGo aims to enhance service delivery and capture significant market opportunities in virtual care.
Bull says
- ↑Upgraded 2026 revenue guidance to $300–315M.
- ↑Non-migrant mobile health revenues jumped 78% YoY.
- ↑Generated $33.6M Q2 cash flow; held $128.7M cash.
- ↑SteadyMD acquisition expands virtual and in-person care.
- ↑Medical transportation volumes at record levels.
- ↑Analyst revisions positive; liquidity remains strong.
Bear says
- ↓Q2 revenue declined 8.8% YoY to $73.4M.
- ↓FY26 adjusted EBITDA loss widened to $17–22M.
- ↓Q2 cash balance fell to $48.1M from $59.9M.
- ↓SteadyMD integration risks may disrupt efficiency.
- ↓Potential Medicare RPM reimbursement cuts threaten revenue.
- ↓High volatility and negative profitability factors persist.
Earnings Call · Q2 2025 · Mgmt. Guidance
Updated 08-18-2026neutral
Transcript signals
Read full transcript analysis ›